These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2824807)

  • 1. Site-specific mutations at a picornavirus VP3/VP1 cleavage site disrupt in vitro processing and assembly of capsid precursors.
    Parks GD; Palmenberg AC
    J Virol; 1987 Dec; 61(12):3680-7. PubMed ID: 2824807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic cleavage of encephalomyocarditis virus capsid region substrates by precursors to the 3C enzyme.
    Parks GD; Baker JC; Palmenberg AC
    J Virol; 1989 Mar; 63(3):1054-8. PubMed ID: 2536819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.
    Ansardi DC; Morrow CD
    J Virol; 1993 Dec; 67(12):7284-97. PubMed ID: 8230452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavages at the three junctions within the foot-and-mouth disease virus capsid precursor (P1-2A) by the 3C protease are mutually independent.
    Kristensen T; Newman J; Guan SH; Tuthill TJ; Belsham GJ
    Virology; 2018 Sep; 522():260-270. PubMed ID: 30055516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a short, highly conserved, motif required for picornavirus capsid precursor processing at distal sites.
    Kristensen T; Belsham GJ
    PLoS Pathog; 2019 Jan; 15(1):e1007509. PubMed ID: 30657784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
    Ansardi DC; Luo M; Morrow CD
    Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase.
    Blair WS; Semler BL
    J Virol; 1991 Nov; 65(11):6111-23. PubMed ID: 1656088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins.
    Ypma-Wong MF; Semler BL
    J Virol; 1987 Oct; 61(10):3181-9. PubMed ID: 3041039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A detailed kinetic analysis of the in vitro synthesis and processing of encephalomyocarditis virus products.
    Jackson RJ
    Virology; 1986 Feb; 149(1):114-27. PubMed ID: 3004023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal region (VP4) of the foot-and-mouth disease capsid precursor (P1-2A) is not required during its synthesis to allow subsequent processing by the 3C protease.
    Kristensen T; Normann P; Belsham GJ
    Virology; 2022 May; 570():29-34. PubMed ID: 35364457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinase 3C-mediated processing of VP1-2A of two hepatitis A virus strains: in vivo evidence for cleavage at amino acid position 273/274 of VP1.
    Probst C; Jecht M; Gauss-Müller V
    J Virol; 1997 Apr; 71(4):3288-92. PubMed ID: 9060697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing of the VP1/2A junction is not necessary for production of foot-and-mouth disease virus empty capsids and infectious viruses: characterization of "self-tagged" particles.
    Gullberg M; Polacek C; Bøtner A; Belsham GJ
    J Virol; 2013 Nov; 87(21):11591-603. PubMed ID: 23966400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic processing of the cardioviral P2 region: primary 2A/2B cleavage in clone-derived precursors.
    Palmenberg AC; Parks GD; Hall DJ; Ingraham RH; Seng TW; Pallai PV
    Virology; 1992 Oct; 190(2):754-62. PubMed ID: 1325705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and site-directed mutagenesis of the primary (2A/2B) cleavage site of the hepatitis A virus polyprotein: functional impact on the infectivity of HAV RNA transcripts.
    Martin A; Escriou N; Chao SF; Girard M; Lemon SM; Wychowski C
    Virology; 1995 Oct; 213(1):213-22. PubMed ID: 7483265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage site mutations in the encephalomyocarditis virus P3 region lethally abrogate the normal processing cascade.
    Hall DJ; Palmenberg AC
    J Virol; 1996 Sep; 70(9):5954-61. PubMed ID: 8709217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing.
    Ryan MD; Belsham GJ; King AM
    Virology; 1989 Nov; 173(1):35-45. PubMed ID: 2554577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of deletion mutants indicates that the 2A polypeptide of hepatitis A virus participates in virion morphogenesis.
    Cohen L; Bénichou D; Martin A
    J Virol; 2002 Aug; 76(15):7495-505. PubMed ID: 12097562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions.
    Ansardi DC; Morrow CD
    J Virol; 1995 Mar; 69(3):1540-7. PubMed ID: 7853487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poliovirus proteinase 3C: large-scale expression, purification, and specific cleavage activity on natural and synthetic substrates in vitro.
    Nicklin MJ; Harris KS; Pallai PV; Wimmer E
    J Virol; 1988 Dec; 62(12):4586-93. PubMed ID: 2846872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1992 Jul; 66(7):4556-63. PubMed ID: 1318418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.